InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Foster-Cheek Kaye I, 董事. Director active across 2 companies, notably AGIOS PHARMACEUTICALS, INC.. Aggregated, 10 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €46k. Activity tracked since 28 May 2021. The latest transaction was filed on 20 June 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Foster-Cheek Kaye I
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
2,816 股Common stockSEC:0001439222-26-000103:0
2,120 股0Common stockSEC:0001439222-25-000057:0
3,388 股0Common stockSEC:0001439222-24-000091:0
1,285 股@ US$31.628.1% 占其流量Common stockSEC:0001439222-24-000061:0
300 股@ US$32.211.9% 占其流量Common stockSEC:0001439222-24-000058:0
25,000 股@ US$18.0989.9% 占其流量Common stockSEC:0001439222-23-000125:0
4,975 股0Common stockSEC:0001439222-23-000097:0
2,200 股0Common stockSEC:0001439222-23-000006:0
1,585 股0Common stockSEC:0001439222-22-000048:0
1,686 股0Common stockSEC:0001439222-21-000053:0
10 条申报中的 10 条
About Foster-Cheek Kaye I
Foster-Cheek Kaye I is Administrateur at AGIOS PHARMACEUTICALS, INC. and Agios Pharmaceuticals, INC. The 10 filings on record cover the period from 2021-06-02 to 2026-06-23 in the sampled recent filings, with sell volume of EUR 46180 and no buy volume; the most frequent transaction nature is Levée d'options.
